Xiaoqi Liu
University of Kentucky(US)Harbin Medical University(CN)Markey Cancer Center(US)Fourth Affiliated Hospital of Harbin Medical University(CN)Second Affiliated Hospital of Harbin Medical University(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Microtubule and mitosis dynamics, Pancreatic and Hepatic Oncology Research, Cancer-related gene regulation, DNA Repair Mechanisms
Most-Cited Works
- → Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer(2018)153 cited
- → p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer(2020)112 cited
- → Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer(2012)109 cited
- → Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)(2018)100 cited
- → Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State(2014)88 cited
- → Plk1-mediated Phosphorylation of Topors Regulates p53 Stability(2009)87 cited